Skip to main content
. 2020 Sep 15;8:570490. doi: 10.3389/fbioe.2020.570490

FIGURE 1.

FIGURE 1

Schematic representation of using an effective epigallocatechin gallate (EGCG)-loaded FU/HA/PG-coated [Poly (D,L-lactide-co-glycolide); PLGA] nanoparticles (NPs) targeting strategy and observation of their putative effects on prostate carcinoma cells.